University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
M

Frontline Therapies in MDS: Hampering Higher-risk MDS

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Mikkael Sekeres
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Mikkael Sekeres
19 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
MDS Biology and Treatment
25:42

2020 Update on MDS Mutational Landscape: What Are the Most Common MD…

University of Miami's 2nd Biennial Miami Leukemia Symposium

R. Bejar

15 views
20:06

2020 Update on Splicing in MDS: How Can We Target Spliceosome-Mutant…

University of Miami's 2nd Biennial Miami Leukemia Symposium

T. Graubert

11 views
22:02

TGF Beta Pathway Inhibition in MDS: Luspatercept Significantly Decre…

University of Miami's 2nd Biennial Miami Leukemia Symposium

A. Verma

115 views
12:19

How to Calculate Risk in MDS Patients?

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

93 views
14:36

Frontline Therapies in MDS: Leveling Lower-risk MDS

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

40 views
05:28

Frontline Therapies in MDS: Hampering Higher-risk MDS

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

19 views
10:48

Hypomethylating Agents as SoC in MDS/AML: Clearance of TP53 Mutation…

University of Miami's 2nd Biennial Miami Leukemia Symposium

D. Sallman

19 views
08:13

Discussion on the Data of Frontline Combination Therapy with APR-246…

University of Miami's 2nd Biennial Miami Leukemia Symposium

D. Sallman

19 views
05:21

Magrolimab (Formerly 5F9) is a First-in-class Macrophage Immune Chec…

University of Miami's 2nd Biennial Miami Leukemia Symposium

D. Sallman

168 views
27:33

Overcoming Adaptive Therapy Resistance in AML: IRAK Signalling (via …

University of Miami's 2nd Biennial Miami Leukemia Symposium

D. Starczynowski

19 views